A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer
Clinical trial NCT06151262 · RECRUITING
Trial details
- NCT number
- NCT06151262
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-20
- Primary completion
- 2025-05-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.